Effects of bradykinin on venous capacitance in health and treated chronic heart failure

Clinical Science

Volumn 116, Issue 5, 2009, Pages 443-450

  Gunaruwan, Prasad ^a   Maher, Abdul ^a   Williams, Lynne ^a   Sharman, James ^a   Schmitt, Matthias ^a   Campbell, Ross ^a   Frenneaux, Michael ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Angiotensin receptor blocker (ARB); Angiotensin converting enzyme inhibitor (ACEI); Bradykinin; Bradykinin receptor; Heart failure; Venous capacitance

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; B 9340; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; BRADYKININ ANTAGONIST; CANDESARTAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL; ICATIBANT; LISINOPRIL; LOSARTAN; NITRATE; PERINDOPRIL; RAMIPRIL; UNCLASSIFIED DRUG; VALSARTAN; WARFARIN; BRADYKININ RECEPTOR; DRUG DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VESSEL CAPACITANCE; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INFUSION; FEMALE; HEART FAILURE; HEART RATE; HUMAN; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RADIONUCLIDE PLETHYSMOGRAPHY; VEIN TONE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FOREARM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOREARM; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, BRADYKININ; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 63449084731     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080096     Document Type: Article

References (32)

1. Cockcroft, J. R., Sciberras, D. G., Goldberg, M. R. and Ritter, J. M. (1993) Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J. Cardiovasc. Pharmacol. 22, 579-584
2. Cockcroft, J. R., Chowienczyk, P. J., Brett, S. E., Bender, N. and Ritter, J. M. (1994) Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. Br. J. Clin. Pharmacol. 38, 317-321
3. Davie, A. P., Dargie, H. J. and McMurray, J. J. (1999) Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. Circulation 100, 268-273
4. Witherow, F.N., Helmy,A., Webb,D. J., Fox, K. A. and Newby, D. E. (2001) Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation 104, 2177-2181
5. Cruden, N. L.,Witherow, F. N., Webb, D. J., Fox, K. A. and Newby, D. E. (2004) Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Arterioscler. Thromb. Vasc. Biol. 24, 1043-1048
6. Dachman, W. D., Ford, G. A., Blaschke, T. F. and Hoffman, B. B. (1993) Mechanism of bradykinin-induced venodilation in humans. J. Cardiovasc. Pharmacol. 21, 241-248
7. Schmitt, M., Blackman, D. J., Middleton, G.W., Cockcroft, J. R. and Frenneaux, M. P. (2002) Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications. Br. J. Clin. Pharmacol. 54, 565-576
8. Farmer, S. G. and Burch, R. M. (1992) Biochemical and molecular pharmacology of kinin receptors. Annu. Rev. Pharmacol. Toxicol. 32, 511-536
9. Kuoppala, A., Shiota, N., Kokkonen, J. O. et al. (2002) Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure. J. Am. Coll. Cardiol. 40, 119-125
10. Nightingale, A. K., Blackman, D. J., Ellis, G. R. et al. (2001) Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction. J. Am. Coll. Cardiol. 37, 1062-1068
11. Schmitt, M., Broadley, A. J., Nightingale, A. K. et al. (2003) Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans. Arterioscler. Thromb. Vasc. Biol. 23, 1833-1838
12. Gunaruwan, P., Schmitt, M., Taylor, J., Lee, L., Struthers, A. and Frenneaux, M. (2002) Lack of rapid aldosterone effects on forearm resistance vasculature in health. J. Renin Angiotensin Aldosterone Syst. 3, 123-125
13. Schmitt, M., Gunaruwan, P., Payne, N. et al. (2004) Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arterioscler. Thromb. Vasc. Biol. 24, 911-917
14. Groves, P., Kurz, S., Just, H. and Drexler, H. (1995) Role of endogenous bradykinin in human coronary vasomotor control. Circulation 92, 3424-3430
15. Collier, J. G., Nachev, C. and Robinson, B. F. (1972) Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin. Sci. 43, 455-467
16. Mason, D. T. and Melmon, K. L. (1965) Effects of bradykinin on forearm venous tone and vascular resistance in man. Circ. Res. 17, 106-113
17. Bomtempo, C. A., Santos, G. F., Santos, R. A. and Campagnole-Santos, M. J. (1998) Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate. J. Hypertens. 16, 1797-1804
18. Hornig, B., Kohler, C., Schlink, D., Tatge, H. and Drexler, H. (2003) AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism. Hypertension 41, 1092-1095
19. Mancini, G. B., Henry, G. C., Macaya, C. et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94, 258-265
20. Chen, Z., Tan, F., Erdos, E. G. and Deddish, P. A. (2005) Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension 46, 1368-1373
21. Maguire, S. M., McAuley, D., McGurk, C., Nugent, A. G., Johnston, G. D. and Nicholls, D. P. (2001) Bradykinin infusion in chronic cardiac failure and the effects of captopril. Eur. J. Heart Failure 3, 671-677
22. Cruden, N. L., Tse, G. H., Fox, K. A., Ludlam, C. A., Megson, I. and Newby, D. E. (2005) B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. Arterioscler. Thromb. Vasc. Biol. 25, 772-777
23. Cleland, J. G., John, J. and Houghton, T. (2001) Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure? Curr. Opin. Nephrol. Hypertens. 10, 625-631
24. Cleland, J. G., Findlay, I., Jafri, S. et al. (2004) The Warfarin/ Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am. Heart J. 148, 157-164
25. Al Khadra, A. S., Salem, D. N., Rand, W. M., Udelson, J. E., Smith, J. J. and Konstam, M. A. (1998) Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J. Am. Coll. Cardiol. 31, 419-425
26. Cleland, J. G., Ghosh, J., Freemantle, N. et al. (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur. J. Heart Failure 6, 501-508
27. Davie, A. P. and McMurray, J. J. (2002) Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. Br. J. Clin. Pharmacol. 53, 37-42
28. Aumegeat, V., Lamblin, N., de Groote, P. et al. (2003) Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with angiotensin-converting enzyme inhibitors. Chest 124, 1250-1258
29. Teo, K. K., Yusuf, S., Pfeffer, M. et al. (2002) Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 360, 1037-1043
30. Griffoni, C., Spisni, E., Strillacci, A., Toni, M., Bachschmid, M. M. and Tomasi, V. (2007) Selective inhibition of prostacyclin synthase activity by rofecoxib. J. Cell Mol. Med. 11, 327-338
31. Ritter, J. M., Cockcroft, J. R., Doktor, H. S., Beacham, J. and Barrow, S. E. (1989) Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. Br. J. Clin. Pharmacol. 28, 573-579
32. Heavey, D. J., Barrow, S. E., Hickling, N. E. and Ritter, J. M. (1985) Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 318, 186-188